About this trial
To compare between the efficacy and safety of topical ivermectin alone, microneedling with topical ivermectin and topical salicylic acid in treatment of cutaneous warts.
topical ivermectin 1% will be applied on warts whole night clinical assessment will be done every 2 weeks
Microneedling will be performed on the lesion using a microneedling pen type device with a 1-cm tip diameter at a 2-mm depth setting for 2-3 minutes until pinpoint bleebing occurs 1 mL of topical ivermectin 1% will be applied on to the wart tissue.
Sessions: Sessions will be performed every 2 weeks until complete cure or for maximum 6 sessions (total 3 month)
Eligibility criteria
Qualifiers
patients with cutaneous non genital warts aged 11:80 y.
No concurrent systemic or topical treatment of warts
Disqualifiers
Genital warts.
Pregnancy and lactation.
History of any bleeding, clotting disorder or using anticoagulants
Chronic systemic diseases such as chronic renal failure, hepaticinsufficiency, and cardiovascular disorders.
Trial design
Treatments tested in this trial
- Ivermectin
- microneedling
- Salicylic Acid